Vikram Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 05-01-2025
- Paid Up Capital ₹ 9.80 M
as on 05-01-2025
- Company Age 46 Year, 26 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.91 Cr
as on 05-01-2025
- Satisfied Charges ₹ 5.30 Cr
as on 05-01-2025
- Revenue 31.85%
(FY 2021)
- Profit 46.85%
(FY 2021)
- Ebitda 8.45%
(FY 2021)
- Net Worth 4.70%
(FY 2021)
- Total Assets 27.79%
(FY 2021)
About Vikram Pharmaceuticals
The Company is engaged in the Automotive Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 9.80 M.
The company currently has active open charges totaling ₹2.91 Cr. The company has closed loans amounting to ₹5.30 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ram Kumar, Anjula Aggarwal, Dhruv Gupta, and One other member serve as directors at the Company.
- CIN/LLPIN
U24231CH1978PTC003900
- Company No.
003900
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Dec 1978
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Vikram Pharmaceuticals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ram Kumar  | Director | 03-Feb-2003 | Current |
| Anjula Aggarwal | Director | 06-Feb-2017 | Current |
| Dhruv Gupta | Director | 20-May-2017 | Current |
| Saurabh Aggarwal | Director | 08-Nov-2023 | Current |
Financial Performance of Vikram Pharmaceuticals.
Vikram Pharmaceuticals Pvt Ltd, for the financial year ended 2021, experienced significant growth in revenue, with a 31.85% increase. The company also saw a substantial improvement in profitability, with a 46.85% increase in profit. The company's net worth moved up by a moderate rise of 4.7%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vikram Pharmaceuticals?
In 2021, Vikram Pharmaceuticals had a public holding of 1.02%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Himachal Fasteners Pvt LtdActive 34 years 6 monthsRam Kumar, Anjula Aggarwal and 1 more are mutual person
- Him Auto Products Private LimitedActive 29 years 4 months
Ram Kumar, Anjula Aggarwal and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 04 Dec 2020 | ₹2.34 Cr | Open |
Member Secretary Creation Date: 05 Nov 2012 | ₹2.60 M | Open |
Sbi Bank Creation Date: 21 Aug 2003 | ₹1.37 M | Open |
How Many Employees Work at Vikram Pharmaceuticals?
Vikram Pharmaceuticals has a workforce of 42 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vikram Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vikram Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
